Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0018133 (
graft-versus-host disease
)
18,032
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Recent evidence suggests that Ia+ Langerhans cells may be a primary target for destruction in cutaneous
graft-versus-host disease
(
GVHD
). Although it is generally accepted that T lymphocytes with helper/inducer phenotype are essential, the identity of the effector cells is still controversial. We therefore investigated whether a variety of Ia-reactive cloned helper T cells with different cross-reactivities and functions in vitro can induce cutaneous
GVHD
following intradermal inoculation into the footpad of the appropriate recipients, whose Ia antigens are able to stimulate the T cells to proliferate in vitro. All cloned T cells tested caused significant footpad swelling in their appropriate recipients with a course typical for local cutaneous delayed-type hypersensitivity (DTH) reactions. Two of these cloned T cells,
SK 1
and BB5, induced local histologic changes consistent with grades 2-3 of cutaneous
GVHD
in the appropriate allogeneic or syngeneic recipients at 48-72 hr after their intradermal inoculation. Immunohistochemical studies using monoclonal antibodies demonstrated that not only injected cloned T cells but also Lyt-1+ cells derived from the recipient migrate into the epidermis and are responsible for the destruction seen in cutaneous
GVHD
. In epidermis in which cutaneous
GVHD
had been induced, expression of Ia by keratinocytes and the damage of Ia+LC were observed. These results suggest that Ia+LC and Ia+ keratinocytes may play an important role in the infiltration of Ia-reactive T cells responsible for cutaneous
GVHD
.
...
PMID:Induction of cutaneous graft-versus-host disease by allo- or self-Ia-reactive helper T cells in mice. 243 72